| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |